ClinicalTrials.Veeva

Menu

7T MRS in Parkinson's Disease

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Completed

Conditions

Parkinson's Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01237210
0803M28421

Details and patient eligibility

About

This study is looking for healthy controls and patients with Parkinson's (PD) to perform an MR scan.

  1. The neurochemical profile of the SN of patients with PD as measured by high field MRS will differ from that of healthy controls, in that glutathione will be lower due to oxidative stress, lactate will be higher due to mitochondrial dysfunction, the gliosis markers myo-inositol and glutamine will be higher due to inflammation (glial activation) and N-acetylaspartate and glutamate will be lower due to neuronal loss/damage.
  2. There will be a relationship between neurochemical changes and disease severity.

Enrollment

78 patients

Sex

All

Ages

45 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Parkinson's disease Group

  • Parkinson's disease (clinical diagnostic criteria)
  • Age 45-75 years inclusive
  • Able to safely undergo MRI scanning
  • Absence of diabetes and smoking
  • Capable of giving informed consent

Healthy Control Group

  • Age 45-75 years inclusive
  • Able to safely undergo MRI scanning
  • Absence of diabetes and smoking
  • Capable of giving informed consent

Exclusion criteria

Parkinson's disease Group

  • Dementia (clinically determined by PI Dr. Tuite)
  • Diagnosis of atypical parkinsonism
  • Inability to safely undergo MRI scanning
  • Inability to give informed consent
  • Unstable medical conditions
  • Present smoker
  • Diabetic (on oral or injectable medications for diabetes)
  • Taken coenzyme Q10 or Vitamin E in the 2 weeks prior to the scan
  • Does not meet age criteria

Healthy Control Group

  • Has a 1st degree relative with PD
  • Dementia (clinically determined by PI Dr. Tuite)
  • Inability to safely undergo MRI scanning
  • Inability to give informed consent
  • Unstable medical conditions
  • Present smoker
  • Diabetic (on oral or injectable medications for diabetes)
  • Taken coenzyme Q10 or Vitamin E in the 2 weeks prior to the scan
  • Does not meet age criteria

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems